Insider · CIK 0001229448

SULAT JAMES R

Reports to the SEC for 10 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001229448

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-11-14	Keenova Therapeutics plcD Disposition to Issuer	Director	DDisposition to Issuer	−53.1K sh	—	—	0
2023-06-16	Keenova Therapeutics plcD Disposition to Issuer	Director	DDisposition to Issuer	−26.3K sh	—	—	53,122
2023-06-16	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−3,154 sh	$1.28	−$4,037.12	79,399
2023-03-15	Keenova Therapeutics plcP Purchase	Director	PPurchase	+15K sh	$8.54	+$128K	82,553
2023-03-14	Keenova Therapeutics plcP Purchase	Director	PPurchase	+15K sh	$8.42	+$126K	67,553
2023-01-03	Keenova Therapeutics plcA Award	Director	AAward	+26.3K sh	—	—	52,553
2022-08-16	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	26,276
2022-07-01	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+48.8K sh	—	—	48,809
2022-06-13	XCUREXICURE, INC. · Employee Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2021-09-27	Arch Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000
2021-09-27	Arch Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+250K sh	—	—	250,000
2021-06-02	XCUREXICURE, INC. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2021-01-02	XCUREXICURE, INC. · Stock Option (right to buy)A Award	Director	AAward	+43.4K sh	—	—	43,386
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.3K sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.3K sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.1K sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.8K sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,575 sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,800 sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−317 sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−35.1K sh	—	—	0
2020-11-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,543 sh	—	—	0
2020-06-22	Arch Therapeutics, Inc.O Exercise Out-of-Money	Director	OExercise Out-of-Money	+455K sh	$81818.28	+$37.2B	1,376,813
2020-06-22	Arch Therapeutics, Inc.Series J Warrant (right to buy)P Purchase	Director	PPurchase	+341K sh	—	—	340,910
2020-06-22	Arch Therapeutics, Inc.Series D Warrant (right to buy)O Exercise Out-of-Money	Director	OExercise Out-of-Money	+455K sh	—	—	0
2020-06-02	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+21.3K sh	—	—	21,289
2020-06-02	AMAG PHARMACEUTICALS, INC.A Award	Director	AAward	+10.3K sh	—	—	35,090
2019-12-20	Arch Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+300K sh	—	—	300,000
2019-06-20	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,356 sh	—	—	0
2019-06-20	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+4,356 sh	—	—	54,090
2019-06-19	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-05-24	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$8.85	+$88.5K	49,734
2019-05-24	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2019-05-16	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+17.3K sh	—	—	17,326
2019-05-16	AMAG PHARMACEUTICALS, INC.A Award	Director	AAward	+8,116 sh	—	—	24,821
2018-09-06	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+13.5K sh	$14.79	+$200K	39,734
2018-09-06	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−13.5K sh	—	—	13,500
2018-07-19	Arch Therapeutics, Inc.A Award	Director	AAward	+110K sh	—	—	370,000
2018-07-19	Arch Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+110K sh	—	—	110,000
2018-07-16	Arch Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$0.37	+$11.1K	260,000
2018-07-16	Arch Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2018-06-20	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,734 sh	—	—	0
2018-06-20	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsA Award	Director	AAward	+4,356 sh	—	—	4,356
2018-06-20	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+8,855 sh	—	—	8,855
2018-06-20	MOMENTA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,734 sh	—	—	26,234
2018-06-07	AMAG PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+7,543 sh	—	—	7,543
2018-06-07	AMAG PHARMACEUTICALS, INC.A Award	Director	AAward	+3,578 sh	—	—	16,705
2017-06-20	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+11.2K sh	—	—	11,207
2017-06-20	MOMENTA PHARMACEUTICALS INCRestricted Stock UnitsA Award	Director	AAward	+5,734 sh	—	—	5,734

Recent filings

Accepted (ET)
Nov 164
SULAT JAMES R0001104659-23-119106
SEC(opens sec.gov)
Jun 294
SULAT JAMES R0001104659-23-076465
SEC(opens sec.gov)
Mar 164
SULAT JAMES R0001104659-23-033302
SEC(opens sec.gov)
Jan 54
SULAT JAMES R0001104659-23-001541
SEC(opens sec.gov)
Sep 144
SULAT JAMES R0001104659-22-100151
SEC(opens sec.gov)
Jul 64
SULAT JAMES R0000899243-22-025533
SEC(opens sec.gov)
Jun 154
SULAT JAMES R0001209191-22-036945
SEC(opens sec.gov)
Oct 14
SULAT JAMES R0001104659-21-121634
SEC(opens sec.gov)
Jun 44
SULAT JAMES R0001209191-21-038326
SEC(opens sec.gov)
Jan 54
SULAT JAMES R0001209191-21-001201
SEC(opens sec.gov)
Nov 174
SULAT JAMES R0001104659-20-126327
SEC(opens sec.gov)

Companies

Address

C/O MAXYGEN, INC. 515 GALVESTON DRIVE

REDWOOD CITY, CA, 94063